Market Overview:
The global preclinical CRO market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for preclinical services from biopharmaceutical companies, government and academic institutes, and medical device companies. Additionally, the growing focus on drug discovery and development is also contributing to the growth of this market. On the basis of type, the global preclinical CRO market can be segmented into bioanalysis and DMPK studies, toxicology testing, and others. The bioanalysis and DMPK studies segment is expected to account for a major share of this market in 2018 owing to its growing demand from biopharmaceutical companies for conducting pharmacokinetic (PK) studies as part of their drug discovery process. On the basis of application, this market can be divided into biopharmaceutical companies, government and academic institutes, medical device companies,,and others segments.
Product Definition:
Preclinical CRO is a Contract Research Organization that provides support to pharmaceutical and biotech companies in preclinical research. Preclinical CROs help clients with activities such as target identification, lead identification and optimization, assay development, and toxicology studies. The importance of preclinical CROs lies in their ability to provide high-quality services that can help reduce the time and cost of drug development.
Bioanalysis and DMPK Studies:
Bioanalysis and DMPK studies are the core of preclinical CRO. It is used for all kind of toxicological tests during drug development such as acute toxicity, chronic toxicity, dermal toxicity & systemicoxicity, genetic toxicology and cytotoxicology.
Toxicology Testing:
The toxicology testing is the science of determining the effect of chemical substances on living organisms. It is used as a scientific method to study the adverse effects caused by drugs and other chemicals in animals before human trials. The main objective of preclinical CRO (contract research organization) industry is to provide safety information about new drug candidates for humans, which will eventually lead to FDA approval for marketing or commercialization of products in U.S.
Application Insights:
The biopharmaceutical companies segment dominated the global preclinical CRO market in terms of revenue in 2017. The growth can be attributed to factors such as increasing R&D activities for the development of novel drugs and growing emphasis on drug discovery and testing. For instance, according to a study published by Global Research Analysts, Inc., in 2018, pharmaceutical companies are investing more than USD 300 billion annually for research & development activities globally. In addition, according to an article published by Statista in 2016-2017, around 20% - 30% of a company¢â‚¬â„¢s total budget is usually spent on research & development every year. These factors indicate that there is a high demand for preclinical studies across various industries which will eventually drive the market over the forecast period.
Medical device companies also conduct extensive R&D activities related to new product developments along with continuous efforts toward improving existing products or services based on consumer requirements and technological advancements.
Regional Analysis:
North America dominated the global preclinical CRO market in 2017. This can be attributed to the presence of a large number of biopharmaceutical and medical device companies, which are engaged in drug development activities. Moreover, government support for R&D is high in this region as compared to other regions; hence it attracts many pharmaceutical and biopharmaceutical companies for drug development activities.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing focus of governments on promoting economic growth through job creation and attracting investments from various sectors such as healthcare & life sciences, IT & electronics among others. The growing interest of foreign players in emerging markets such as China and India has resulted into an increase demand for services over there which will drive growth over next eight years (2018-2030).
Growth Factors:
- Increasing demand for preclinical services from the pharmaceutical and biotechnology industries as they seek to reduce the time and costs associated with drug development.
- The increasing number of new drugs being developed, which is driving up demand for preclinical services.
- The growing use of outsourcing by the pharmaceutical and biotechnology industries to reduce costs and improve efficiency.
- The increasing focus on early-stage drug discovery by the pharmaceutical industry, which is driving up demand for preclinical services.
Scope Of The Report
Report Attributes
Report Details
Report Title
Preclinical CRO Market Research Report
By Type
Bioanalysis and DMPK Studies, Toxicology Testing, Others
By Application
Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies
By Companies
Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi AppTec, Medpace, Pharmaceutical Product Development, Paraxel
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Preclinical CRO Market Report Segments:
The global Preclinical CRO market is segmented on the basis of:
Types
Bioanalysis and DMPK Studies, Toxicology Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River Laboratories
- Laboratory Corporation of America
- Envigo
- Eurofins Scientific
- PRA Health Science
- Wuxi AppTec
- Medpace
- Pharmaceutical Product Development
- Paraxel
Highlights of The Preclinical CRO Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bioanalysis and DMPK Studies
- Toxicology Testing
- Others
- By Application:
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Preclinical CRO Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Preclinical CRO is the process of conducting research in animals before human trials are started. This helps to ensure that any new drug or treatment is safe and effective before it is put into widespread use.
Some of the key players operating in the preclinical cro market are Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi AppTec, Medpace, Pharmaceutical Product Development, Paraxel.
The preclinical cro market is expected to register a CAGR of 7.5%.
1 Executive Summary2 Assumptions and Acronyms Used
3 Research Methodology
4 Preclinical CRO Industry Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.2 Macro-Economic Factors
4.2.1 Industry Outlook
4.3 Preclinical CRO Industry Dynamics
4.3.1 Market Drivers
4.3.2 Market Restraints
4.3.3 Opportunity
4.3.4 Market Trends
4.4 Preclinical CRO Industry - Supply Chain
4.5 Global Preclinical CRO Industry Forecast
4.5.1 Preclinical CRO Industry Size (US$ Mn) and Y-o-Y Growth
4.5.2 Preclinical CRO Industry Absolute $ Opportunity
5 Global Preclinical CRO Industry Analysis and Forecast by Services
5.1 Market Trends
5.2 Introduction
5.2.1 Basis Point Share (BPS) Analysis by Services
5.2.2 Y-o-Y Growth Projections by Services
5.3 Preclinical CRO Industry Size Forecast by Services
5.3.1 Bioanalysis and DMPK Studies
5.3.2 Toxicology Testing (Kindly Refer Page No. 13 -14)
5.3.3 Others
5.4 Absolute $ Opportunity Assessment by Services
5.5 Market Attractiveness/Growth Potential Analysis by Services
6 Global Preclinical CRO Industry Analysis and Forecast by End-user
6.1 Market Trends
6.2 Introduction
6.2.1 Basis Point Share (BPS) Analysis by End-user
6.2.2 Y-o-Y Growth Projections by End-user
6.3 Preclinical CRO Industry Size Forecast by End-user
6.3.1 Biopharmaceutical Companies
6.3.2 Government and Academic Institutes
6.3.3 Medical Device Companies
6.4 Absolute $ Opportunity Assessment by End-user
6.5 Market Attractiveness/Growth Potential Analysis by End-user
7 Global Preclinical CRO Industry Analysis and Forecast by Region
7.1 Market Trends
7.2 Introduction
7.2.1 Basis Point Share (BPS) Analysis by Region
7.2.2 Y-o-Y Growth Projections by Region
7.3 Preclinical CRO Industry Size Forecast by Region
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Latin America
7.3.5 Middle East and Africa (MEA)
7.4 Absolute $ Opportunity Assessment by Region
7.5 Market Attractiveness/Growth Potential Analysis by Region
8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Market Trends
8.3 Patient Data
8.4 Current Impact Analysis
8.5 Future Impact Analysis
8.6 Economic Impact Analysis
8.7 Government Policies
8.8 Investment Scenario
9 North America Preclinical CRO Industry Analysis and Forecast
9.1 Introduction
9.1.1 Basis Point Share (BPS) Analysis by Country
9.1.2 Y-o-Y Growth Projections by Country
9.2 North America Preclinical CRO Industry Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Absolute $ Opportunity Assessment by Country
9.4 North America Preclinical CRO Industry Size Forecast by Services
9.4.1 Bioanalysis and DMPK Studies
9.4.2 Toxicology Testing
9.4.3 Others
9.5 Basis Point Share (BPS) Analysis by Services
9.6 Y-o-Y Growth Projections by Services
9.7 North America Preclinical CRO Industry Size Forecast by End-user
9.7.1 Biopharmaceutical Companies
9.7.2 Government and Academic Institutes
9.7.3 Medical Device Companies
9.8 Basis Point Share (BPS) Analysis by End-user
9.9 Y-o-Y Growth Projections by End-user
9.10 Market Attractiveness/Growth Potential Analysis
9.10.1 By Country
9.10.2 By Services
9.10.3 By End-user
10 Europe Preclinical CRO Industry Analysis and Forecast
10.1 Introduction
10.1.1 Basis Point Share (BPS) Analysis by Country
10.1.2 Y-o-Y Growth Projections by Country
10.2 Europe Preclinical CRO Industry Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Absolute $ Opportunity Assessment by Country
10.4 Europe Preclinical CRO Industry Size Forecast by Services
10.4.1 Bioanalysis and DMPK Studies
10.4.2 Toxicology Testing
10.4.3 Others
10.5 Basis Point Share (BPS) Analysis by Services
10.6 Y-o-Y Growth Projections by Services
10.7 Europe Preclinical CRO Industry Size Forecast by End-user
10.7.1 Biopharmaceutical Companies
10.7.2 Government and Academic Institutes
10.7.3 Medical Device Companies
10.8 Basis Point Share (BPS) Analysis by End-user
10.9 Y-o-Y Growth Projections by End-user
10.10 Market Attractiveness/Growth Potential Analysis
10.10.1 By Country
10.10.2 By Services
10.10.3 By End-user
11 Asia Pacific Preclinical CRO Industry Analysis and Forecast
11.1 Introduction
11.1.1 Basis Point Share (BPS) Analysis by Country
11.1.2 Y-o-Y Growth Projections by Country
11.2 Asia Pacific Preclinical CRO Industry Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 Rest of Asia Pacific (APAC)
11.3 Absolute $ Opportunity Assessment by Country
11.4 Asia Pacific Preclinical CRO Industry Size Forecast by Services
11.4.1 Bioanalysis and DMPK Studies
11.4.2 Toxicology Testing
11.4.3 Others
11.5 Basis Point Share (BPS) Analysis by Services
11.6 Y-o-Y Growth Projections by Services
11.7 Asia Pacific Preclinical CRO Industry Size Forecast by End-user
11.7.1 Biopharmaceutical Companies
11.7.2 Government and Academic Institutes
11.7.3 Medical Device Companies
11.8 Basis Point Share (BPS) Analysis by End-user
11.9 Y-o-Y Growth Projections by End-user
11.10 Market Attractiveness/Growth Potential Analysis
11.10.1 By Country
11.10.2 By Services
11.10.3 By End-user
12 Latin America Preclinical CRO Industry Analysis and Forecast
12.1 Introduction
12.1.1 Basis Point Share (BPS) Analysis by Country
12.1.2 Y-o-Y Growth Projections by Country
12.2 Latin America Preclinical CRO Industry Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America
12.3 Absolute $ Opportunity Assessment by Country
12.4 Latin America Preclinical CRO Industry Size Forecast by Services
12.4.1 Bioanalysis and DMPK Studies
12.4.2 Toxicology Testing
12.4.3 Others
12.5 Basis Point Share (BPS) Analysis by Services
12.6 Y-o-Y Growth Projections by Services
12.7 Latin America Preclinical CRO Industry Size Forecast by End-user
12.7.1 Biopharmaceutical Companies
12.7.2 Government and Academic Institutes
12.7.3 Medical Device Companies
12.8 Basis Point Share (BPS) Analysis by End-user
12.9 Y-o-Y Growth Projections by End-user
12.10 Market Attractiveness/Growth Potential Analysis
12.10.1 By Country
12.10.2 By Services
12.10.3 By End-user
13 Middle East & Africa Preclinical CRO Industry Analysis and Forecast
13.1 Introduction
13.1.1 Basis Point Share (BPS) Analysis by Country
13.1.2 Y-o-Y Growth Projections by Country
13.2 MEA Preclinical CRO Industry Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of MEA
13.3 Absolute $ Opportunity Assessment by Country
13.4 MEA Preclinical CRO Industry Size Forecast by Services
13.4.1 Bioanalysis and DMPK Studies
13.4.2 Toxicology Testing
13.4.3 Others
13.5 Basis Point Share (BPS) Analysis by Services
13.6 Y-o-Y Growth Projections by Services
13.7 MEA Preclinical CRO Industry Size Forecast by End-user
13.7.1 Biopharmaceutical Companies
13.7.2 Government and Academic Institutes
13.7.3 Medical Device Companies
13.8 Basis Point Share (BPS) Analysis by End-user
13.9 Y-o-Y Growth Projections by End-user
13.10 Market Attractiveness/Growth Potential Analysis
13.10.1 By Country
13.10.2 By Services
13.10.3 By End-user
14 Competition Landscape
14.1 Global Preclinical CRO Industry: Market Share Analysis
14.2 Preclinical CRO Distributors and Customers
14.3 Preclinical CRO Industry: Competitive Dashboard
14.4 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.4.1 Envigo Corporation
14.4.2 Eurofins Scientific
14.4.3 ICON Plc.
14.4.4 Laboratory Corporation of America, Inc.
14.4.5 Medpace, Inc.
14.4.6 MPI research
14.4.7 PARAXEL International Corporation
14.4.8 Pharmaceutical Product Development (PPD), LLC
14.4.9 PRA Health Sciences, Inc
14.4.10 Wuxi AppTec
